文献速递临床试验与 GCP流行病学与生物统计

钩端螺旋体病试验核心结局集开发(COS-LEP):用于评估人类钩端螺旋体病临床治疗干预的核心结局集开发研究方案

Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core outcome set for the evaluation of clinical therapeutic interventions for human leptospirosis.
PubMed 文献 · Trials · 2025-01-06

钩端螺旋体病治疗研究缺乏标准化结局指标,本方案拟按COMET框架开发首个钩端螺旋体病核心结局集(COS)。方法包括系统综述、医护人员与患者访谈、德尔菲调查及混合共识会议,以形成未来临床试验可统一报告的最小结局集合。

要点

  • 钩端螺旋体病治疗研究方法学不一致且缺乏标准化结局指标。
  • COS-LEP按COMET框架分四步开发核心结局集。
  • 该核心结局集将用于未来钩端螺旋体病随机对照试验设计。

核心结论

  • 本方案描述开发首个用于人类钩端螺旋体病研究的核心结局集的方法,将有助于统一钩端螺旋体病治疗研究并为未来严谨的国际临床试验构建高质量证据基础。

研究设计与样本

  • COS-LEP研究采用COMET initiative框架标准化的核心结局集开发方法,包括系统综述、聚焦访谈、德尔菲调查和混合共识会议四个步骤。

主要发现

  • 系统综述将纳入报告治疗反应与安全性结局及测量方法的定量与定性文献。
  • 聚焦访谈将用定性方法探索医护人员和接受过钩端螺旋体病治疗者感兴趣的结局。
  • 将通过国际共识的德尔菲调查流程缩小结局选择范围。
  • 将与关键利益相关方举行混合共识会议以构建最终核心结局集。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Leptospirosis is a zoonotic bacterial infection occurring worldwide. It is of particular public health concern due to its global distribution, epidemic potential and high mortality without appropriate treatment. The method for the management of leptospirosis, particularly in severe disease, is clouded by methodological inconsistency and a lack of standardized outcome measures. The study this protocol details aims to develop a core outcome set (COS) for leptospirosis research. A COS is a set of outcomes with international consensus as a minimum for reporting in future studies focusing on leptospirosis. Establishing a COS will contribute to harmonizing Leptospirosis treatment research and will be instrumental in constructing a high-quality evidence base to feed into a planned future rigorous international clinical trial on leptospirosis. METHODS: The COS-LEP study will employ a COS development methodology standardized by the COMET initiative framework. This includes (1) a systematic review of available quantitative and qualitative literature reporting therapeutic response and safety outcomes and measures; (2) focused interviews with healthcare professional and people treated for leptospirosis exploring outcomes of interests using qualitative methodology; (3) narrowing the choice of outcomes by international consensus using a Delphi survey process; and (4) undertaking a hybrid consensus meeting with key stakeholders to build the final COS. DISCUSSION: This protocol describes the method to develop the first core outcome set for use in human leptospirosis studies. This will not only be a key feature in the design of a future definitive randomized controlled trial, but also provide a structure for clinicians and researchers collecting treatment cohort data in the various settings where leptospirosis is a public health issue.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lee N, Smith C, Bailey R, et al. Core Outcome Set development for LEPtospirosis trials (COS-LEP): a study protocol to develop a core outcome set for the evaluation of clinical therapeutic interventions for human leptospirosis. Trials. 2025. PMID: 39762892. doi:10.1186/s13063-024-08713-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。